Clinical Trial Update: Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of basiliximab in hepatitis C virus–positive patients undergoing liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Basiliximab (basiliximab)

Snippet

Sponsor: Novartis | Conditions: Liver Transplant | Phase 3 | Status: COMPLETED